A detailed history of Fred Alger Management, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Fred Alger Management, LLC holds 35,182 shares of DXCM stock, worth $3.04 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
35,182
Previous 494,644 92.89%
Holding current value
$3.04 Million
Previous $56.1 Million 95.8%
% of portfolio
0.01%
Previous 0.28%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$64.0 - $116.06 $29.4 Million - $53.3 Million
-459,462 Reduced 92.89%
35,182 $2.36 Million
Q2 2024

Aug 14, 2024

SELL
$110.31 - $140.45 $4.85 Million - $6.17 Million
-43,934 Reduced 8.16%
494,644 $56.1 Million
Q1 2024

May 15, 2024

SELL
$114.22 - $140.1 $54.8 Million - $67.2 Million
-479,869 Reduced 47.12%
538,578 $74.7 Million
Q4 2023

Feb 14, 2024

BUY
$75.49 - $124.16 $17.1 Million - $28.2 Million
227,090 Added 28.7%
1,018,447 $126 Million
Q3 2023

Nov 14, 2023

BUY
$86.06 - $137.93 $7.44 Million - $11.9 Million
86,478 Added 12.27%
791,357 $73.8 Million
Q2 2023

Aug 14, 2023

BUY
$112.47 - $130.98 $12.8 Million - $14.9 Million
114,127 Added 19.32%
704,879 $90.6 Million
Q1 2023

May 15, 2023

BUY
$104.0 - $122.92 $38 Million - $44.9 Million
365,035 Added 161.72%
590,752 $68.6 Million
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $14.2 Million - $20.4 Million
166,596 Added 281.79%
225,717 $25.6 Million
Q3 2022

Nov 14, 2022

SELL
$76.35 - $94.18 $1.17 Million - $1.44 Million
-15,316 Reduced 20.58%
59,121 $4.76 Million
Q2 2022

Aug 15, 2022

SELL
$67.99 - $132.89 $13.5 Million - $26.4 Million
-198,369 Reduced 72.71%
74,437 $5.55 Million
Q1 2022

May 16, 2022

SELL
$94.08 - $130.2 $4.81 Million - $6.65 Million
-51,097 Reduced 15.78%
272,806 $140 Million
Q4 2021

Feb 14, 2022

SELL
$129.87 - $162.82 $3.22 Million - $4.04 Million
-24,796 Reduced 7.11%
323,903 $174 Million
Q3 2021

Nov 15, 2021

SELL
$106.71 - $143.18 $3.48 Million - $4.66 Million
-32,580 Reduced 8.54%
348,699 $191 Million
Q2 2021

Aug 16, 2021

SELL
$80.99 - $107.93 $2.23 Million - $2.97 Million
-27,496 Reduced 6.73%
381,279 $163 Million
Q1 2021

May 17, 2021

BUY
$84.79 - $104.74 $1.6 Million - $1.97 Million
18,823 Added 4.83%
408,775 $147 Million
Q4 2020

Feb 16, 2021

SELL
$78.0 - $104.5 $4.13 Million - $5.54 Million
-53,003 Reduced 11.97%
389,952 $144 Million
Q3 2020

Nov 13, 2020

SELL
$95.51 - $112.95 $3.54 Million - $4.19 Million
-37,065 Reduced 7.72%
442,955 $183 Million
Q2 2020

Aug 14, 2020

SELL
$62.68 - $105.34 $8.97 Million - $15.1 Million
-143,136 Reduced 22.97%
480,020 $195 Million
Q1 2020

May 15, 2020

SELL
$47.79 - $75.63 $6.17 Million - $9.76 Million
-129,050 Reduced 17.16%
623,156 $168 Million
Q4 2019

Feb 14, 2020

BUY
$36.62 - $57.29 $11 Million - $17.2 Million
299,754 Added 66.25%
752,206 $165 Million
Q3 2019

Nov 14, 2019

BUY
$35.53 - $43.8 $5.47 Million - $6.75 Million
154,088 Added 51.64%
452,452 $67.5 Million
Q2 2019

Aug 14, 2019

SELL
$27.84 - $38.92 $2.74 Million - $3.83 Million
-98,528 Reduced 24.82%
298,364 $44.7 Million
Q1 2019

May 14, 2019

SELL
$28.07 - $38.18 $2.18 Million - $2.96 Million
-77,580 Reduced 16.35%
396,892 $47.3 Million
Q4 2018

Feb 14, 2019

SELL
$26.99 - $37.37 $4.91 Million - $6.8 Million
-182,012 Reduced 27.73%
474,472 $56.8 Million
Q3 2018

Nov 14, 2018

BUY
$23.35 - $36.72 $454,250 - $714,350
19,454 Added 3.05%
656,484 $93.9 Million
Q2 2018

Jul 19, 2018

SELL
$17.54 - $25.22 $3.71 Million - $5.34 Million
-211,555 Reduced 24.93%
637,030 $60.5 Million
Q1 2018

May 10, 2018

BUY
$13.06 - $18.54 $7.31 Million - $10.4 Million
559,425 Added 193.47%
848,585 $62.9 Million
Q4 2017

Feb 14, 2018

BUY
$11.12 - $15.38 $2.03 Million - $2.81 Million
182,777 Added 171.81%
289,160 $16.6 Million
Q3 2017

Nov 14, 2017

BUY
$11.36 - $18.98 $1.21 Million - $2.02 Million
106,383
106,383 $5.21 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $33.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.